EX Program by Truth Initiative Offers a Proven Path to Success WASHINGTON, Dec. 23, 2024 /PRNewswire/ -- Almost half (48%) of…
MIAMI, FL / ACCESSWIRE / December 19, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a preclinical-stage pharmaceutical company focused on developing…
U.S. FDA Orphan Drug exclusivity provides seven years of market exclusivity for Libervant® (diazepam) Buccal Film in the United States…
Development Services Span Tech Transfer, Process Assessment and Method Validation for Fill and Finish of NRS-033 for Planned Phase 2…
Toronto, Ontario--(Newsfile Corp. - December 18, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or…
Toronto, Ontario--(Newsfile Corp. - December 18, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or…
ASPEN, Colo., Dec. 17, 2024 /PRNewswire/ -- BRAIN.ONE, a groundbreaking personalized brain fitness platform, is pleased to announce a partnership…
The interview with Dr. John Barr and Jim Patton tackles medication safety and how PillSafe Technologies secures prescriptions, prevents abuse,…
As Medical Officer, Dr. Stacy will assist in reviewing addiction and substance-abuse related research and serve as Rehab.com's spokesperson and…
FDA is expected to assign a Prescription Drug User Fee Act (PDUFA) target action date and announce whether Priority Review…
